Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Mara Holdings General Counsel Zabi Nowaid Sells $101K of Stock
Zabi Nowaid, General Counsel, sold 8,376 shares of Mara Holdings, Inc. at $12.10 a share, worth $101K in total on Sep 18, 2026. Shares held after the trade: 890,404 (-0.9%).
Mara Holdings CEO Frederick G. Thiel Sells $315K of Stock
Frederick G. Thiel, CEO, sold 27,505 shares of Mara Holdings, Inc. at $11.45 a share, worth $315K in total on Sep 17, 2026. Shares held after the trade: 4,308,192 (-0.6%).
Bloom Energy Chief Commercial Officer Aman Joshi Sells $972K of Stock
Aman Joshi, Chief Commercial Officer, sold 3,601 shares of Bloom Energy Corp at $269.94 a share, worth $972K in total on Sep 16, 2026. Shares held after the trade: 155,529 (-2.3%).
Bloom Energy CAO Maciej Kurzymski Sells $616K of Stock
Maciej Kurzymski, CAO, sold 2,295 shares of Bloom Energy Corp at $268.42 a share, worth $616K in total on Sep 16, 2026. Shares held after the trade: 77,391 (-2.9%).
Newegg Commerce Director Fred Faching Chang Sells $683K of Stock
Fred Faching Chang, Director, sold 52,082 shares of Newegg Commerce, Inc. at $13.05 to $13.18 a share (average $13.11) in 2 transactions, worth $683K in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 2,947,549 (-1.0%).
Skye Bioscience Director Andrew J. Schwab Sells $62.3K of Stock
Andrew J. Schwab, Director, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $62.3K of Stock
5AM Partners VII LLC, 10% Owner, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
Bloom Energy Insider Shawn Marie Soderberg Sells $775K of Stock
Shawn Marie Soderberg sold 2,870 shares of Bloom Energy Corp at $270.07 a share, worth $775K in total on Sep 16, 2026. Shares held after the trade: 126,500 (-2.2%).
Bloom Energy Chief Operations Officer Satish Chitoori Sells $775K of Stock
Satish Chitoori, Chief Operations Officer, sold 2,870 shares of Bloom Energy Corp at $270.06 a share, worth $775K in total on Sep 16, 2026. Shares held after the trade: 202,494 (-1.4%).
Adobe Chair and CEO Shantanu Narayen Sells $31.3M of Stock
Shantanu Narayen, Chair and CEO, sold 125,000 shares of Adobe Inc. at $246.09 to $253.64 a share (average $250.76) in 12 transactions, worth $31.3M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 249,340 (-6.6%).
CapsoVision Insider Ching Hang Shen Buys $5M of Stock
Ching Hang Shen bought 878,734 shares of CapsoVision, Inc at $5.69 a share, worth $5M in total on Sep 15, 2026. Shares held after the trade: 2,926,655 (+42.9%).
Kinder Morgan VP (Pres., Products Pipelines) Michael P. Garthwaite Sells $47.7K of Stock
Michael P. Garthwaite, VP (Pres., Products Pipelines), sold 1,550 shares of Kinder Morgan, Inc. at $30.80 a share, worth $47.7K in total on Sep 16, 2026. Shares held after the trade: 48,863 (-3.1%).
Williams Sonoma EVP CFO Jeffrey Howie Sells $672K of Stock
Jeffrey Howie, EVP CFO, sold 3,045 shares of Williams Sonoma Inc at $217.39 to $224.42 a share (average $220.61) in 8 transactions, worth $672K in total on Sep 16, 2026. Shares held after the trade: 34,138 (-0.7%).
Synaptics Insider Lisa Bodensteiner Sells $30.9K of Stock
Lisa Bodensteiner sold 334 shares of Synaptics Inc at $92.63 a share, worth $30.9K in total on Sep 18, 2026. Shares held after the trade: 77,518 (-0.4%).
Revolution Medicines Chief Development Officer Alan B. Sandler Sells $67K of Stock
Alan B. Sandler, Chief Development Officer, sold 336 shares of Revolution Medicines, Inc. at $199.30 a share, worth $67K in total on Sep 16, 2026. Shares held after the trade: 52,868 (-0.6%).
Revolution Medicines Insider Anthony Mancini Sells $348K of Stock
Anthony Mancini sold 1,747 shares of Revolution Medicines, Inc. at $199.30 a share, worth $348K in total on Sep 16, 2026. Shares held after the trade: 42,116 (-4.0%).
Williams Sonoma President & CEO Laura Alber Sells $7.74M of Stock
Laura Alber, President & CEO, sold 35,000 shares of Williams Sonoma Inc at $219.17 to $222.86 a share (average $221.20) in 5 transactions, worth $7.74M in total on Sep 16, 2026. Shares held after the trade: 853,524 (-0.3%).
Revolution Medicines Insider Stephen Michael Kelsey Sells $1.11M of Stock
Stephen Michael Kelsey sold 5,569 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $1.11M in total on Sep 16, 2026. Shares held after the trade: 286,307 (-1.9%).
Revolution Medicines COO Margaret A. Horn Sells $990K of Stock
Margaret A. Horn, COO, sold 4,967 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $990K in total on Sep 16, 2026. Shares held after the trade: 149,680 (-3.2%).
Revolution Medicines Insider Mark A. Goldsmith Sells $2.79M of Stock
Mark A. Goldsmith sold 13,988 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $2.79M in total on Sep 16, 2026. Shares held after the trade: 253,342 (-5.2%).
Revolution Medicines SVP & General Counsel Jeff Cislini Sells $671K of Stock
Jeff Cislini, SVP & General Counsel, sold 3,366 shares of Revolution Medicines, Inc. at $195.01 to $199.30 a share (average $199.24) in 2 transactions, worth $671K in total on Sep 16, 2026. Shares held after the trade: 52,541 (-5.9%).
Revolution Medicines CFO Jack Anders Sells $808K of Stock
Jack Anders, CFO, sold 4,053 shares of Revolution Medicines, Inc. at $195.00 to $199.30 a share (average $199.24) in 2 transactions, worth $808K in total on Sep 16, 2026. Shares held after the trade: 119,216 (-3.2%).
General American Investors Co President & CEO Jeffrey W. Priest Buys $93.8K of Stock
Jeffrey W. Priest, President & CEO, bought 4,000 shares of General American Investors Co Inc at $23.46 a share, worth $93.8K in total on Sep 18, 2026. Shares held after the trade: 44,691 (+9.8%).
Blackstone Director Joseph Baratta Sells $12.4M of Stock
Joseph Baratta, Director, sold 100,000 shares of Blackstone Inc. at $123.35 to $124.13 a share (average $123.80) in 2 transactions, worth $12.4M in total on Sep 18, 2026. Shares held after the trade: 771,599 (-7.0%).
International Tower Hill Mines CEO David Victor Wiens Buys $200K of Stock
David Victor Wiens, CEO, bought 83,682 shares of International Tower Hill Mines Ltd at $2.39 a share, worth $200K in total on Sep 16, 2026. Shares held after the trade: 684,047 (+13.9%).
Savers Value Village Insider William T. Allen Sells $241K of Stock
William T. Allen sold 26,151 shares of Savers Value Village, Inc. at $9.22 a share, worth $241K in total on Sep 16, 2026. Shares held after the trade: 28,861 (-47.5%).
Blackstone Mortgage Trust President Fernando Austin Pena Sells $15.1K of Stock
Fernando Austin Pena, President, sold 1,127 shares of Blackstone Mortgage Trust, Inc. at $13.42 a share, worth $15.1K in total on Sep 17, 2026. Shares held after the trade: 71,772 (-1.5%).
Blackstone Mortgage Trust CFO Marcin Urbaszek Sells $11.6K of Stock
Marcin Urbaszek, CFO, sold 864 shares of Blackstone Mortgage Trust, Inc. at $13.42 a share, worth $11.6K in total on Sep 17, 2026. Shares held after the trade: 23,960 (-3.5%).
Glaukos Chief Development Officer Tomas Navratil Sells $243K of Stock
Tomas Navratil, Chief Development Officer, sold 1,453 shares of Glaukos Corp at $163.20 to $170.95 a share (average $166.91) in 6 transactions, worth $243K in total on Sep 16, 2026. Shares held after the trade: 72,437 (-0.3%).
Credit Acceptance Corporation entered into consent judgments with 40 state attorneys general and the District of Columbia to resolve a 2023 lawsuit and a multi-state investigation into its lending practices. The company will pay $15.5 million to the states, $60 million to a consumer remediation trust, and provide an estimated $634 million in debt relief via balance waivers. The settlement also mandates enhanced consumer disclosures and dealer oversight for a period of five to seven years.
Counterparty
Attorneys General of 40 States and the District of Columbia